Nutrivert

Nutrivert was founded in 2016, is headquartered in United States, and has $2.4M in recorded funding across 1 round.

Founded
2016
Business Model
B2B
Total Funding
$2.4M
Last Round
$2.4M Extension RoundApr 2026
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round for this company. The full record is or through the API.

About

Nutrivert develops alternatives to antibiotics for livestock production. The company was formed to commercialize antibiotic-replacement technologies developed with university researchers after its founders investigated how low antibiotic doses promote animal growth. Its research has included studies in pigs and broiler chickens to refine a compound called Nutrivert LDPP, with a team combining veterinary research, animal-health, regulatory, and commercial experience.

Summary

Nutrivert is a Biotech company based in United States, founded in 2016. It has raised $2.4M in total across 1 round, most recently a $2.4M Extension Round in Apr 2026.

Funding History

Extension RoundExtension RoundApr 2026
$2.4M

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Nutrivert on Indexed.vc
<a href="https://indexed.vc/companies/nutrivert"><img src="https://indexed.vc/api/badge/company/nutrivert" alt="Nutrivert on Indexed.vc" width="260" height="76" /></a>